Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Age1
Age1

Age1

DeepTech NativeSan Francisco, United StatesActiveWebsite
Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Age1 is a longevity-focused venture capital fund investing in companies that target biological aging mechanisms. The thesis is straightforward: aging is the primary risk factor for most major diseases, and addressing it directly is both scientifically sound and commercially viable.

The firm makes early-stage investments in longevity therapeutics and supports founders developing novel approaches t...

Similar Funds

4BIO Capital

4BIO Capital

Geneva, Switzerland

DeepTech NativeBiotechSeedSeries A
Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Accelerator Life Science Partners

Accelerator Life Science Partners

Seattle, United States

DeepTech NativeBiotechMedTechSeedSeries A
Agent Capital

Agent Capital

Waltham, United States

DeepTech NativeBiotechMedTechNeurotechSeedSeries A
ARTIS Ventures

ARTIS Ventures

San Francisco, United States

DeepTech NativeBiotechAI InfrastructureMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.